CFDA Orders Hong Kong Suspension Of Cold Pill To Test For Banned Drug
This article was originally published in PharmAsia News
Executive Summary
The China FDA ordered Hong Kong's health authority to suspend sales of Shenzhen Tongan Pharmaceutical's Vitamin C Yinqiao cold medicine until it can determine the pill's makeup.